Clinical Trials on Advanced Thymic Epithelial Tumour in Denmark
Total 146 results
-
Morten Mau-SoerensenHospices Civils de Lyon; Gustave Roussy, Cancer Campus, Grand Paris; Institut... and other collaboratorsUnknownThymoma | Advanced Thymic Epithelial TumourDenmark, France
-
Herlev HospitalGENISTerminatedAdvanced Solid TumorsDenmark
-
MonTa Biosciences ApSAllucentRecruitingAdvanced Solid TumorBelgium, Denmark, Spain
-
AstraZenecaCompletedAdvanced Solid TumorsDenmark, Canada
-
Repare TherapeuticsRoche Pharma AGActive, not recruitingAdvanced Solid TumorUnited States, Canada, Denmark, United Kingdom
-
Repare TherapeuticsDebiopharm International SARecruitingAdvanced Solid TumorUnited States, Canada, Denmark
-
Vejle HospitalRecruitingSkin Diseases | Eyelid Diseases | Eyelid Tumor | BCC | BCC - Basal Cell CarcinomaDenmark
-
Herlev HospitalCompleted
-
Ulrik LassenUniversity of Copenhagen; Herlev HospitalActive, not recruitingRecurrent Adult Brain TumorDenmark
-
Day One Biopharmaceuticals, Inc.Pacific Pediatric Neuro-Oncology ConsortiumRecruitingAdvanced Solid Tumor | Low-grade GliomaUnited States, Israel, Korea, Republic of, Denmark, Singapore, Netherlands, Canada, Australia, Germany, Switzerland, United Kingdom
-
Merck Sharp & Dohme LLCTerminatedAdvanced Solid TumorsCanada, United States, Denmark, Israel, Switzerland
-
Incyte CorporationActive, not recruitingAdvanced Solid TumorsUnited States, Sweden, Netherlands, Norway, Denmark
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsUnited States, Germany, Norway, Netherlands, Belgium, Denmark, Sweden, Switzerland
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
Novartis PharmaceuticalsCompletedcMET-dysregulated Advanced Solid TumorsUnited States, Spain, Italy, Bulgaria, United Kingdom, France, Denmark
-
Novartis PharmaceuticalsCompletedcMET Dysegulation Advanced Solid TumorsAustria, Denmark, Sweden, United Kingdom, Spain, Germany, Netherlands, United States
-
Hoffmann-La RocheCompletedAdvanced/Metastatic Solid TumorsUnited States, Belgium, Denmark, Spain, Netherlands, Canada, Italy
-
Rigshospitalet, DenmarkRecruiting
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors, Excluding Breast CancerNetherlands, Switzerland, Denmark, United States
-
University of AarhusAarhus University HospitalCompletedCarcinoma, Hepatocellular | Neuroendocrine TumorsDenmark
-
Aarhus University HospitalRecruitingAnal Cancer | Circulating Tumor Cell | Oligometastatic Disease | Human Papilloma Virus | Locally Advanced Squamous Cell CarcinomaDenmark
-
University of AarhusDanish Cancer SocietyRecruiting
-
Inge Marie SvaneCompleted
-
Novartis PharmaceuticalsCompletedALK-positive Advanced TumorsItaly, Spain, Denmark, United States
-
Rigshospitalet, DenmarkEnrolling by invitationNeuroendocrine Tumors | Neuroendocrine Carcinoma | Neuroendocrine Carcinoma Metastatic | GEP-NETDenmark
-
Bristol-Myers SquibbActive, not recruitingAdvanced or Metastatic Solid TumorsUnited States, Spain, Italy, Canada, Germany, United Kingdom, Denmark, Finland
-
Scandion Oncology A/SAlcedis GmbHRecruitingMetastatic Pancreatic Adenocarcinoma | Locally Advanced Pancreatic Adenocarcinoma | Inoperable Disease | Localized Pancreatic AdenocarcinomaDenmark, Germany
-
Rigshospitalet, DenmarkTerminatedGlioblastomaDenmark
-
Rigshospitalet, DenmarkThe Novo Nordic FoundationCompleted
-
University of AarhusEnrolling by invitationGlioblastoma MultiformeDenmark
-
Rigshospitalet, DenmarkUnknown
-
Herlev and Gentofte HospitalNot yet recruitingKidney Cancer | Urologic Neoplasms | Metastatic Renal Cell Carcinoma | Urologic Cancer | Advanced Renal Cell Carcinoma | Kidney NeoplasmDenmark
-
Allarity TherapeuticsCompletedPhase 1: Advanced or Refractory Solid Tumours | Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin CancerDenmark
-
Philogen S.p.A.Immatics Biotechnologies GmbHTerminatedMerkel Cell CarcinomaGermany, Austria, Denmark, France, Spain, United Kingdom
-
CytoVac A/SCompleted
-
Hoffmann-La RocheRecruitingAdvanced Solid TumorsUnited States, Belgium, Spain, France, United Kingdom, Canada, Denmark
-
Novartis PharmaceuticalsRecruitingAdvanced Solid Tumors Which Are cMET-dependentGermany, Korea, Republic of, Belgium, Italy, Singapore, United States, Denmark, Spain, France, Canada
-
Rigshospitalet, DenmarkWyeth is now a wholly owned subsidiary of Pfizer; University of Copenhagen; Roche...CompletedGlioblastoma MultiformeDenmark
-
BayerRecruitingLocally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene FusionUnited States, Austria, Denmark, Germany, Italy, Norway, Spain, United Kingdom, Brazil, Russian Federation, Switzerland, Taiwan, Canada, China, Australia, Greece, Belgium, Sweden, Korea, Republic of, France, Argentina, Finland, Ireland and more
-
Ulrik LassenCompleted
-
Rigshospitalet, DenmarkEnrolling by invitationSarcoma | Lymphoma | Breast Cancer | Neuroendocrine Tumors | Neuroendocrine Carcinoma | Neuroendocrine Carcinoma MetastaticDenmark
-
Odense University HospitalNovo Nordisk A/S; Rigshospitalet, Denmark; Danish Cancer Society; Region of Southern...CompletedMalignant Glioma | Life ExperiencesDenmark
-
University Hospital Bispebjerg and FrederiksbergUnknownNevus, Pigmented | Basal Cell Carcinoma | Malignant Melanoma | Seborrheic KeratosisDenmark
-
Rigshospitalet, DenmarkUnknownBreast Cancer | Ovarian Cancer | Neuroendocrine CarcinomaDenmark
-
PfizerTerminatedLocally Advanced or Metastatic Solid Tumors | Genes, BRCA 1United States, Belgium, Spain, Denmark, Japan, France, Italy, Netherlands, United Kingdom
-
Odense University HospitalUnknown
-
Aarhus University HospitalNovoCure Ltd.Completed
-
Jakob StenmanNovartis; Advanced Accelerator ApplicationsRecruitingNeuroblastoma | Neuroblastoma RecurrentSweden, Denmark, Lithuania, Norway, Netherlands
-
Ulrik LassenUniversity of Copenhagen; Boehringer IngelheimCompleted
-
Rigshospitalet, DenmarkDanish Center for Interventional Research in Radiation Oncology (CIRRO)Terminated